Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJG5G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,410
Award facts
- Contract value 100% obligated
- $15,409.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,409.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a targeted cancer therapy used primarily in oncology treatment. The award, issued on January 6, 2026, is classified as a child contract with an ultimate completion date of January 28, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was awarded on a fully competitive basis with no set-aside designation.
This award is issued under AmerisourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 31, 2031. The broader IDC serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. AmerisourceBergen, as a major pharmaceutical distributor, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of delivery orders with firm fixed pricing structures that range significantly in value, demonstrating its capability to efficiently fulfill essential pharmaceutical requirements for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FJG5G?
SPE2DR26FJG5G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FJG5G worth?
The government has obligated $15,410 on SPE2DR26FJG5G.
Is contract SPE2DR26FJG5G an order under another contract?
Yes. SPE2DR26FJG5G is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG5G competed?
The extent of competition for SPE2DR26FJG5G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award